Lillys

Eli Lilly’s obesity drug beats rival in head-to-head trial – where Cramer sees stocks move next

New trial data has solidified the Club's lead position, holding off Eli Lilly in the highly competitive obesity drug race.…

6 days ago

FDA approves Eli Lilly’s weight-loss drug Zepbound for treatment of sleep apnea

An Eli Lilly & Co. Zepbound injector pen displayed in the Brooklyn borough of New York, United States, on Thursday,…

6 days ago